What's Going On With Organigram Global Stock Thursday?
Organigram Global Inc. (NASDAQ:OGI) shares rose in Thursday's premarket session after the company confirmed a 65.2 million Canadian dollar private placement investment from British American Tobacco's (NYSE:BTI) subsidiary.
BAT Funding Strengthens Sanity Deal
The financing includes the subscription of 14,027,074 shares at 3.00 Canadian dollars per share (42.08 million Canadian dollars) and exercise top-up rights for 9,897,356 shares at 2.335854 Canadian dollars per share (23.12 million Canadian dollars), totaling 65.2 million Canadian dollars in gross proceeds.
The immediate impact of the announcement is increased financial clarity and reduced funding uncertainty surrounding Organigram's proposed acquisition of Sanity Group GmbH. The proceeds will support the cash portion of the 113.4 million euro upfront consideration, along with related transaction expenses and general working capital.
This follows Wednesday's disclosure that the company was in advanced negotiations for this same 65.2 million Canadian dollar investment.
The confirmed investment strengthens Organigram's balance sheet and signals continued backing from British American Tobacco, which is already a shareholder in both Organigram and Sanity. That alignment reinforces confidence in the strategic rationale of building a global pure-play cannabis platform with expanded exposure to key European markets.
Technical Analysis
The stock is currently trading 4.8% above its 20-day simple moving average (SMA) but 6.2% below its 100-day SMA, suggesting short-term strength while indicating longer-term challenges. Shares have increased 4.55% over the past 12 months and are currently closer to their 52-week lows than their highs, reflecting cautious market sentiment.
The RSI is at 41.29, which is considered neutral territory, suggesting that the stock is neither overbought nor oversold. Meanwhile, the MACD is at -0.0919, below its signal line at -0.0735, indicating bearish pressure on the stock.
The combination of a neutral RSI and a bearish MACD suggests mixed momentum, suggesting traders should watch for potential shifts in market sentiment.
- Key Resistance: $2.00
- Key Support: $1.50
Earnings Outlook
Organigram Global is slated to provide its next financial update on May 11, 2026.
- EPS Estimate: Loss of 1 cent (Down from 22 cents)
- Revenue Estimate: $54.67 million (Up from $45.70 million)
- Valuation: P/E of 12.2x (Indicates value opportunity)
OGI Price Action: Organigram Global shares were up 8.70% at $1.50 during premarket trading on Thursday.
Image via Shutterstock
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Salesforce surges! Is the “software doomsday” over? Q3 guidance exceeds expectations, expands cooperation with Anthropic | Financial Report Insights
Salesforce reported Q2 revenue of $11.35 billion, up 11% year-on-year; net profit reached $3.53 billion, an 87% increase year-on-year. Q3 revenue guidance is between $11.42 billion and $11.5 billion, with remaining performance obligations for the period totaling $33.5 billion, both surpassing market expectations. AI product ARR is nearing $4 billion, with Agentforce surging 240% year-on-year. The company also announced an in-depth collaboration with Anthropic to launch "Claudeforce". Salesforce shares rose as much as 14% after hours.
Basent or reshaping US bond issuance strategy? Wall Street debates cutting long-term US bond issuance, November refinancing meeting becomes key
U.S. Treasury Secretary Janet Yellen's recent, more proactive involvement in the U.S. Treasury market is prompting Wall Street to reassess the government's future debt financing strategies.
"Depreciation trades" make a comeback! Gold and Bitcoin ETF attract about $7 billion in five days as two major scarce assets strengthen together
As concerns over the U.S. fiscal deficit, government debt, and the outlook for the dollar resurface in the market, investors are flocking to both gold and bitcoin simultaneously, instead of choosing between the two assets.
Nvidia's last quarter revenue doubled and exceeded expectations; this quarter is expected to surpass the $100 billion mark for the first time, with next fiscal year's growth guidance crushing estimates | Earnings Watch
In the second fiscal quarter, Nvidia reported its highest year-over-year revenue growth in two years, with data center revenue increasing 117% year-over-year and a gross margin steady at 75% compared to the previous quarter. The company recorded nearly $7.8 billion in net gains from equity securities for the quarter. For the third fiscal quarter, the midpoint of revenue guidance indicates a year-over-year slowdown to nearly 90%. Excluding data center computing revenue from China, this did not surpass the most optimistic institutional expectations. The gross margin guidance midpoint slipped to 74%, slightly below expectations. Nvidia stated that Rubin is accelerating into full-scale production. Jensen Huang said that AI has reached an inflection point, and computing power now translates directly into revenue. After the earnings report, shares initially dropped 4% in after-hours trading. However, as the earnings call revealed a projected 70% increase in next fiscal year revenue and Amazon pledged to substantially increase its adoption of Nvidia products, the stock rebounded to nearly a 5% gain after hours.
Crypto prices
More
